Arca Biopharma | ABIO - Pre Tax Profit


Arca Biopharma reported $-29.58M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Amgen USD 3.92B 2.35B Sep/2025
Arca Biopharma USD -29.58M 694K Dec/2025
Biogen USD 557.3M 186.7M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 11.69B 6.85B Dec/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD 56.84M 63.78M Dec/2025
CSL USD 2.61B 1.21B Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Daiichi Sankyo JPY 106.73B 48.96B Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Grifols EUR 257.85M 190.87M Dec/2024
Laboratory Of America USD 337M 32.3M Sep/2025
Myriad Genetics USD 4.6M 3.4M Dec/2025
Otsuka Holdings JPY 75.26B 91.16B Dec/2025
Pfizer USD 3.33B 290M Sep/2025
United Therapeutics USD 444M 6M Dec/2025